# US 2001/0025154 A1 · Flexible wound covering based on fibrin and process for its production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0025154 A1
- Document ID: US20010025154A1
- Status: Published application
- Kind: A1
- Application number: 09/846,320
- Filed: 2001-05-02
- Published: 2001-09-27
- Earliest claimed: 1998-11-06
- Assignees: Aventis Behring GmbH
- Inventors: Mirna Rapp
- Web page: https://patentgrep.com/patent/US20010025154A1

## CPC

- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61L 26/0042: {Fibrin; Fibrinogen}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- Y10S 602/90: Method of making bandage structure
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

A biodegradable, flexible wound covering based on fibrin and a process for its preparation are described, in which a fibrinogen solution is subjected to a single-stage or multistage dialysis, then a flexible fibrin web is formed by action of an aqueous thrombin solution on the fibrinogen solution and this is subsequently subjected to freeze-drying.

## Claims

### Claim 1

A flexible wound covering based on fibrin, wherein the wound covering contains a fibrin web which is produced from a fibrinogen which is largely or completely free of dialyzable constituents.

### Claim 2 (depends on 1)

A flexible wound covering as claimed in claim 1, wherein the fibrin web is firmly combined with a biodegradable support material.

### Claim 3 (depends on 1)

A flexible wound covering as claimed in claim 1, wherein the fibrin web contains 10 to 80% by weight of glycerol per unit of fibrin.

### Claim 4 (depends on 2)

A flexible wound covering as claimed in claim 2, wherein the fibrin web contains 10 to 80% by weight of glycerol per fibrin unit.

### Claim 5

A process for the production of a flexible wound covering based on fibrin, which comprises subjecting a fibrinogen solution to a single-stage or multistage dialysis, then forming a flexible fibrin web by action of an aqueous thrombin solution on the fibrinogen solution and subsequently subjecting this to freeze-drying.

### Claim 6 (depends on 5)

The process as claimed in claim 5, wherein the formation of the fibrin web is carried out in the presence of a biodegradable support material onto which the fibrin web deposits as a firmly adhering layer.

### Claim 7 (depends on 6)

The process as claimed in claim 6, wherein the biodegradable support material consists of natural or chemically modified collagen, keratin, gelatin, carbohydrates or cellulose derivatives.

### Claim 8 (depends on 6)

The process as claimed in claim 6, wherein the biodegradable support material consists of a polymer from the group consisting of the polyhydroxycarboxylic acids, the polyesters, the polycyanoacrylates, the polyamino acids, the polyalcohols or the silicones.

### Claim 9 (depends on 5)

The process as claimed in claim 5, wherein the fibrinogen solution also additionally contains factor XIII.

### Claim 10 (depends on 5)

The process as claimed in claim 5, wherein the fibrinogen solution is dialyzed in one stage with a solution containing a complexing agent and a physiologically compatible inorganic salt.

### Claim 11 (depends on 5)

The process as claimed in claim 5, wherein the fibrinogen solution is dialyzed in one stage with a solution containing a complexing agent and subsequently a physiologically compatible inorganic salt is added to the fibrinogen solution.

### Claim 12 (depends on 5)

The process as claimed in claim 5, wherein the dialysis is carried out in two stages, the fibrinogen solution first being dialyzed with a solution of a physiologically compatible inorganic salt.

### Claim 13 (depends on 10)

The process as claimed in claim 10, wherein the complexing agent employed for the dialysis of the fibrinogen solution is an aqueous solution of an alkali metal salt of ethylenediaminetetraacetic acid (EDTA), of oxalic acid or of citric acid.

### Claim 14 (depends on 10)

The process as claimed in claim 10, wherein the concentration of the complexing agent in the dialysis bath is 1 to 20 mM, preferably 1 to 5 mM.

### Claim 15 (depends on 10)

The process as claimed in claim 10, wherein the physiologically compatible inorganic salt in the dialysis bath is employed in an amount of up to 0.5 percent by weight.

### Claim 16 (depends on 10)

The process as claimed in claim 10, wherein the physiologically compatible inorganic salt employed is NaCl.

### Claim 17 (depends on 5)

The process as claimed in claim 5, wherein a water-soluble calcium salt is added to the thrombin solution.

### Claim 18 (depends on 17)

The process as claimed in claim 17, wherein the water-soluble calcium salt is added in an amount from 0.5 to 40 mM.

### Claim 19 (depends on 5)

The process as claimed in claim 5, wherein the fibrinogen is employed in an amount from 10 to 25 g/l and the thrombin is employed in an amount of less than 1000 I.U./ml.

### Claim 20 (depends on 5)

The process as claimed in claim 5, wherein active compounds promoting wound healing are added to the fibrin web.

### Claim 21 (depends on 20)

The process as claimed in claim 20, wherein glycerol is added to the fibrinogen in an amount of 0.2 to 0.1 percent by volume during the preparation of the fibrin web.

### Claim 22 (depends on 5)

A flexible wound covering based on fibrin, which is obtainable as claimed in claim 5.

### Claim 23 (depends on 1)

The use of a wound covering as claimed in claim 1 for the hemostasis of internal and external wounds.

### Claim 24 (depends on 1)

The use of a wound covering as claimed in claim 1 as a support material for active compounds promoting wound healing.
